|
|
Preparation and Neutralization Activity of Anti-Canine Parvovirus VP2 Protein Single-chain Antibody |
LI Tong-tong,SONG Cai-ling,YANG Kai-yue,WANG Wen-jing,CHEN Hui-yu,LIU Ming() |
State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China |
|
|
Abstract Objective: Single chain fragment variable(ScFv) is the smallest functional structural unit with the antigen-binding specificity of the parent antibody. Due to its affinity and low immunogenicity, ScFv has broad application prospects in medical treatment and diagnosis. To reduce the host immune rejection during clinical treatment with heterologous murine monoclonal antibody (McAb) in canine, ScFv were prepared against canine parvovirus (CPV) using a prokaryotic expression system. Methods: Total RNA was extracted from hybridoma cell lines specific for CPV,amplification of the antibody heavy chain variable region (VH) gene and the light chain variable region (VL) gene from the reverse transcription cDNA into the expression vector pOPE101. The recombinant plasmid was transformed into E. coli for expression, and the expressed protein was identified by Western blot. The activity of the ScFv was detected by ELISA, and the ScFv purified by affinity chromatography was identified by virus neutralization test. Results: The recombinant plasmid pOPE101-ScFv was successfully constructed. The correct expression of single-chain antibody in E. coli was determined by western blot. The ability of the fusion protein to specifically bind to the virus was verified by ELISA and virus neutralization test. The potency was 1∶40 (0.014 μg/ml). Conclusion: A ScFv with neutralizing activity was obtained using an E. coli expression system, which provides a basis for clinical immunotherapy for CPV disease.
|
Received: 18 October 2019
Published: 18 May 2020
|
|
Corresponding Authors:
Ming LIU
E-mail: liuming04@126.com
|
|
|
[1] |
Decaro N, Buonavoglia C . Canine parvovirus-A review of epidemiological and diagnostic aspects,with emphasis on type 2c. Veterinary Microbiology, 2012,155(1):1-12.
doi: 10.1016/j.vetmic.2011.09.007
pmid: 21962408
|
|
|
[2] |
Mohyedini S, Jamshidi S, Rafati S , et al. Comparison of immunochromatographic rapid test with molecular method in diagnosis of canine parvovirus. Iranian Journal of Veterinary Medicine, 2013,75:51-67.
|
|
|
[3] |
Thomas J, Singh M, Goswami T K , et al. Polymerase chain reaction based epidemiological investigation of canine parvoviral disease in dogs at Bareilly region. Veterinary World, 2014,7(11):929-932.
doi: 10.14202/vetworld.
|
|
|
[4] |
Wu H, Li X, Wang L , et al. Molecular epidemiological survey of canine parvovirus in domestic dogs in four provinces, China. Virus Disease, 2018,29:113-117.
doi: 10.1007/s13337-018-0427-7
pmid: 29607369
|
|
|
[5] |
Mira F, Dowgier G, Purpari G , et al. Molecular typing of a novel canine parvovirus type 2a mutant circulating in Italy. Infection Genetics & Evolution, 2018,61:67-73.
doi: 10.1016/j.meegid.2018.03.010
pmid: 29548803
|
|
|
[6] |
Zhou P, Zeng W, Zhang X , et al. The genetic evolution of canine parvovirus - A new perspective. PLoS One, 2017,12(3):1-13.
doi: 10.1371/journal.pone.0175035
pmid: 28362831
|
|
|
[7] |
宋桂强, 龙贵伟, 廖金 等. 犬细小病毒病的研究进展. 中国畜牧兽医, 2007,34(3):98-100.
|
|
|
[7] |
Song G Q, Long G W, Liao J , et al. Advance in the Research of Canine Parvovirus. China Animal Husbandry & Veterinary Medicine, 2007,34(3):98-100.
|
|
|
[8] |
王彤光, 陈谊, 邓建玲 . 上海地区犬细小病毒病的发病调查及几种治疗方法的应用. 黑龙江畜牧兽医, 2005,(8):55-57.
|
|
|
[8] |
Wang T G, Chen Y, Deng J L . Investigation of the incidence of canine parvovirus disease in Shanghai and the application of several therapeutic methods. Heilongjiang Husbandry & Veterinary Medicine, 2005,(8):55-57.
|
|
|
[9] |
宋永鸿 . 西宁地区犬细小病毒病的流行与防治. 青海畜牧兽医杂志, 2005,35(1):48.
|
|
|
[9] |
Song Y H . Epidemic and prevention of canine parvovirus disease in Xining. Qinghai Husbandry and Veterinary Medicine Journal, 2005,35(1):48.
|
|
|
[10] |
Ahmad Z A, Yeap S K, Ali A M , et al. scFv antibody: principles and clinical application. Clinical and Developmental Immunology, 2012,2012:1-15.
doi: 10.1155/2012/980250
pmid: 22474489
|
|
|
[11] |
Urai C, Wanpen C . Evolution of therapeutic antibodies, influenza virus biology, influenza, and influenza immunotherapy. BioMed Research International, 2018,2018:1-23.
|
|
|
[12] |
Yokota T, Milenic D E, Whitlow M , et al. Rapid tumor penetration of a single-chain fv and comparison with other immunoglobulin forms. Cancer Research, 1992,52(12):3402-3408.
pmid: 1596900
|
|
|
[13] |
Sapats S I, Heine H G, Trinidad L , et al. Generation of chicken single chain antibody variable fragments (scFv) that differentiate and neutralize infectious bursal disease virus (IBDV). Archives of Virology, 2003,148(3):497-515.
doi: 10.1007/s00705-002-0931-2
|
|
|
[14] |
Maneewatch S, Thanongsaksrikul J, Songserm T , et al. Human single-chain antibodies that neutralize homologous and heterologous strains and clades of influenza A virus subtype H5N1. Antiviral Therapy, 2009,14(2):221-230.
pmid: 19430097
|
|
|
[15] |
Li T, Cheng S, Tseng Y , et al. Development of single-chain variable fragments (scFv) against influenza virus targeting hemagglutinin subunit 2 (HA2). Archives of Virology, 2016,161(1):19-31.
doi: 10.1007/s00705-015-2625-6
pmid: 26446888
|
|
|
[16] |
Zhang F, Chen Y, Ke Y , et al. Single chain fragment variable (scFv) antibodies targeting the spike protein of porcine epidemic diarrhea virus provide protection against viral infection in piglets. Viruses, 2019,11(1):58.
doi: 10.3390/v11010058
pmid: 30646521
|
|
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|